We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.89%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$74.4B
AUM Growth
+$7.26B
Cap. Flow
+$2.46B
Cap. Flow %
3.31%
Top 10 Hldgs %
19.47%
Holding
3,107
New
25
Increased
2,535
Reduced
421
Closed
97

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$141M
2
AAPL icon
Apple
AAPL
+$117M
3
ACWX icon
iShares MSCI ACWI ex US ETF
ACWX
+$96.6M
4
AMZN icon
Amazon
AMZN
+$63.7M
5
PLD icon
Prologis
PLD
+$47.7M

Sector Composition

Rank Sector Weight
1 Technology 22.05%
2 Healthcare 14.94%
3 Financials 14.18%
4 Consumer Discretionary 10%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATER icon
2926
Aterian
ATER
$5.37M
$73K ﹤0.01%
7,950
+77
+1% +$965
FOA icon
2927
Finance of America Companies
FOA
$198M
$71K ﹤0.01%
5,570
+395
+8% +$5.79K
DSP icon
2928
Viant Technology
DSP
$265M
$70K ﹤0.01%
17,500
+881
+5% +$3.55K
KORE
2929
DELISTED
KORE Group Holdings
KORE
$70K ﹤0.01%
11,059
+295
+3% +$3.39K
PDYN icon
2930
Palladyne AI
PDYN
$296M
$70K ﹤0.01%
20,742
+517
+3% +$4.41K
LVOX
2931
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$70K ﹤0.01%
23,718
-1,987
-8% -$5.23K
JNCE
2932
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$70K ﹤0.01%
63,066
-63
-0.1% -$90
CELU icon
2933
Celularity
CELU
$20.3M
$67K ﹤0.01%
5,185
+989
+24% +$18.2K
TIL icon
2934
Instil Bio
TIL
$50.3M
$66K ﹤0.01%
5,212
-18
-0.3% -$890
VLTA
2935
DELISTED
Volta Inc.
VLTA
$66K ﹤0.01%
185,435
+820
+0.4% +$623
EIGR
2936
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$64K ﹤0.01%
1,800
-12
-0.7% -$1.44K
MNTS icon
2937
Momentus
MNTS
$92.7M
$63K ﹤0.01%
6
RIG icon
2938
Transocean
RIG
$5.82B
$63K ﹤0.01%
13,784
-2,778
-17% -$10.7K
WGS icon
2939
GeneDx Holdings
WGS
$2.3B
$63K ﹤0.01%
7,220
+15
+0.2% +$331
CURV icon
2940
Torrid Holdings
CURV
$260M
$62K ﹤0.01%
20,959
-61
-0.3% -$249
LOCL icon
2941
Local Bounti
LOCL
$23.5M
$61K ﹤0.01%
3,356
+1,102
+49% +$34.4K
PIII icon
2942
P3 Health Partners
PIII
$38.5M
$61K ﹤0.01%
660
+7
+1% +$1.52K
RDW icon
2943
Redwire
RDW
$3.25B
$61K ﹤0.01%
30,596
+209
+0.7% +$482
RGTI icon
2944
Rigetti Computing
RGTI
$5.99B
$61K ﹤0.01%
83,393
+35,694
+75% +$51K
STLN
2945
Starling Oncology, Inc. Common Stock
STLN
$641M
$61K ﹤0.01%
36,782
+1,154
+3% +$3.24K
FFAI
2946
Faraday Future Intelligent Electric
FFAI
$10.5M
0
THRN
2947
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
$61K ﹤0.01%
16,725
+243
+1% +$1.08K
APPH
2948
DELISTED
AppHarvest, Inc. Common Stock
APPH
$61K ﹤0.01%
107,635
+1,520
+1% +$1.98K
AIRS icon
2949
AirSculpt Technologies
AIRS
$353M
$59K ﹤0.01%
15,961
+342
+2% +$1.59K
PRTY
2950
DELISTED
Party City Holdco Inc.
PRTY
$58K ﹤0.01%
158,935
-1,010
-0.6% -$1.01K

Similar funds

RhumbLine Advisers's Q4 2022 Portfolio in Review

As of Q4 2022, RhumbLine Advisers held 3,107 positions worth $74.4B, up 11% from $67.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

RhumbLine Advisers deployed $2.46B of net new capital in Q4 2022, opening 25 new positions and adding to 2,535 existing holdings. Its largest new stake was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Steel Dynamics, an estimated $18.8M trimmed.

  • RhumbLine Advisers's largest Q4 2022 buy was iShares MSCI ACWI ex US ETF: 2,203,118 shares worth $100M.
  • RhumbLine Advisers added most to Microsoft in Q4 2022, an estimated $141M increase.
  • RhumbLine Advisers's biggest Q4 2022 reduction was Steel Dynamics, cutting an estimated $18.8M.
  • RhumbLine Advisers fully exited Twitter, Inc. in Q4 2022, selling an estimated $56.3M.
  • RhumbLine Advisers's ten largest holdings make up 19% of its $74.4B portfolio in Q4 2022.
  • RhumbLine Advisers opened 25 new positions and closed 97 in Q4 2022.
  • RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $74.4B.

Based on RhumbLine Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.